Determine the Structure of Phosphorylated Modification of Icariin and Its Antiviral Activity Against Duck Hepatitis Virus A

Wen Xiong,Xia Ma,Yi Wu,Yun Chen,Ling Zeng,Jiaguo Liu,Weidong Sun,Deyun Wang,Yuanliang Hu
DOI: https://doi.org/10.1186/s12917-015-0459-9
2015-01-01
BMC Veterinary Research
Abstract:Background Our previous research showed that icariin ( 1 ) and its phosphorylated structural modification ( 2 ) improved the survival and attenuated oxidative stress and liver dysfunction induced by duck virus hepatitis. In this paper, we were one step closer to determine the structure of phosphorylation icariin ( 2 ) by the FT-IR, HRESIMS and 13 C NMR. Anti-DHAV activities of 1 and 2 were compared in duck embryonic hepatocytes (DEHs) cultured in vitro and by artificial infection method in vivo . Additionally, the antiviral mechanisms of replication/release in vitro and the DHAV gene expression in vivo of 1 and 2 were analyzed. Results Compound 2 's molecular formula was C 33 H 42 O 18 P. The results indicated that 1 and 2 effectively resisted DHAV invading DEHs, that they decreased the mortality of ducklings challenged with DHAV, and that 2 performed more effectively. 1 and 2 performed evenly on DHAV release; however, 2 restrained virus replication far more effectively. Since the anti-DHAV mechanisms of 1 and 2 in vitro probably involve suppression of replication and release, 2 ’s better performance in anti-DHAV may result from its far more effectively inhibiting virus replication. Conclusions The compound 2 's chemical structure was defined as 8-prenylkaempferol-4'-methylether-3-rhamnosyl-7-(6'''-phosphate)-glycoside. 1 and 2 exhibited anti-virus activity on DHAV. Our results suggest that 1 and 2 might become an anti-virus plant material candidate.
What problem does this paper attempt to address?